Viewing Study NCT03025893


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2025-12-28 @ 10:39 AM
Study NCT ID: NCT03025893
Status: UNKNOWN
Last Update Posted: 2021-04-19
First Post: 2017-01-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme
Sponsor: Amsterdam UMC, location VUmc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module